Epoqe Pharma
PrivateLast Round
Seed
Jan 28, 2025
Total Funding Raised
$13.93M
Company Overview
Epoqe Pharma operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Seed round in January 2025.
Epoqe Pharma is a biopharmaceutical company that develops novel peptide-based treatments for cardiovascular diseases, with a primary focus on Acute Myocardial Infarct (AMI).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epoqe Pharma Comparables
Compare Epoqe Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ResoTher Pharma | 76% | |
| Zealand Pharma | 70% | |
| Recardio | 69% |
For institutional investors. Book with your work email.
Epoqe Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 28, 2025 | ||||
| Series A | Jan 1, 2025 | ||||
| Grant | Jul 7, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Epoqe Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lundbeck Foundation | Grant |
| Innovation Fund Denmark | Grant |
| Lundbeckfonden BioCapital | Series A, Seed |
| Sofinnova Partners | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2026
Grew 400% QoQ from 1 to 5 employees.
- Nov 8, 2025
Monthly visitors grew 104% MoM, reaching 784.
For institutional investors. Book with your work email.
Epoqe Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Epoqe Pharma's valuation, stock price, and market status.
Is Epoqe Pharma a public or private company?
Epoqe Pharma is a private company.
What is the current stock price of Epoqe Pharma?
Epoqe Pharma is a private company, so its shares have no public market price. Caplight tracks Epoqe Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Epoqe Pharma worth (valuation)?
Valuation information for Epoqe Pharma is not publicly available.
Can I buy Epoqe Pharma stock?
Epoqe Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Epoqe Pharma's last funding round?
Epoqe Pharma's most recent funding round was Seed on January 28, 2025.
Who are the main investors in Epoqe Pharma?
Key investors in Epoqe Pharma include Lundbeckfonden BioCapital.
Will Epoqe Pharma IPO soon?
No public IPO plans have been announced for Epoqe Pharma.
How can I track Epoqe Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Epoqe Pharma's shares on secondary markets.